Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Search results for:
abatacept
abatacept
Brand names:
Orencia, Orencia Prefilled Syringe
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
POWDER FOR INJECTION, INTRAVENOUS
250 mg
Restricted
SOLUTION, SUBCUTANEOUS
50 mg/0.4 mL; 125 mg/mL
VIEW MORE
Disease-Modifying Antirheumatic Drugs
CLASS
923600
Comments:
Abatacept Executive Summary
Chemotherapy Chart
Last updated:
Jan. 25, 2024
Restricted:
abatacept (Orencia) is restricted to use in the Outpatient setting by Rheumatology only
CMS Self-Administered Drug Exclusion List
Orencia (subcutaneous only)
UpToDate
FDA Package Inserts
Acadiana Market Specific P&T Updates
Jackson Market Specific P&T Updates
UpToDate Lexidrug
Abatacept Executive Summary
Chemotherapy Chart